TY - JOUR
T1 - European Society of Cardiology Quality Indicators for the care and outcomes of cardiac pacing
T2 - Developed by the Working Group for Cardiac Pacing Quality Indicators in collaboration with the European Heart Rhythm Association of the European Society of Cardiology
AU - Aktaa, Suleman
AU - Abdin, Amr
AU - Arbelo, Elena
AU - Burri, Haran
AU - Vernooy, Kevin
AU - Blomström-Lundqvist, Carina
AU - Boriani, Giuseppe
AU - Defaye, Pascal
AU - Deharo, Jean Claude
AU - Drossart, Inga
AU - Foldager, Dan
AU - Gold, Michael R.
AU - Johansen, Jens Brock
AU - Leyva, Francisco
AU - Linde, Cecilia
AU - Michowitz, Yoav
AU - Kronborg, Mads Brix
AU - Slotwiner, David
AU - Steen, Torkel
AU - Tolosana, Jose Maria
AU - Tzeis, Stylianos
AU - Varma, Niraj
AU - Glikson, Michael
AU - Nielsen, Jens Cosedis
AU - Gale, Chris P.
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Oxford University Press on behalf of the European Society of Cardiology.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Aims: To develop a suite of quality indicators (QIs) for the evaluation of the care and outcomes for adults undergoing cardiac pacing. Methods and results: Under the auspice of the Clinical Practice Guideline Quality Indicator Committee of the European Society of Cardiology (ESC), the Working Group for cardiac pacing QIs was formed. The Group comprised Task Force members of the 2021 ESC Clinical Practice Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, members of the European Heart Rhythm Association, international cardiac device experts, and patient representatives. We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care by constructing a conceptual framework of the management of patients receiving cardiac pacing, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified-Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. Four domains of care were identified: (i) structural framework, (ii) patient assessment, (iii) pacing strategy, and (iv) clinical outcomes. In total, seven main and four secondary QIs were selected across these domains and were embedded within the 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization therapy. Conclusion: By way of a standardized process, 11 QIs for cardiac pacing were developed. These indicators may be used to quantify adherence to guideline-recommended clinical practice and have the potential to improve the care and outcomes of patients receiving cardiac pacemakers.
AB - Aims: To develop a suite of quality indicators (QIs) for the evaluation of the care and outcomes for adults undergoing cardiac pacing. Methods and results: Under the auspice of the Clinical Practice Guideline Quality Indicator Committee of the European Society of Cardiology (ESC), the Working Group for cardiac pacing QIs was formed. The Group comprised Task Force members of the 2021 ESC Clinical Practice Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy, members of the European Heart Rhythm Association, international cardiac device experts, and patient representatives. We followed the ESC methodology for QI development, which involved (i) the identification of the key domains of care by constructing a conceptual framework of the management of patients receiving cardiac pacing, (ii) the development of candidate QIs by conducting a systematic review of the literature, (iii) the selection of the final set of QIs using a modified-Delphi method, and (iv) the evaluation of the feasibility of the developed QIs. Four domains of care were identified: (i) structural framework, (ii) patient assessment, (iii) pacing strategy, and (iv) clinical outcomes. In total, seven main and four secondary QIs were selected across these domains and were embedded within the 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization therapy. Conclusion: By way of a standardized process, 11 QIs for cardiac pacing were developed. These indicators may be used to quantify adherence to guideline-recommended clinical practice and have the potential to improve the care and outcomes of patients receiving cardiac pacemakers.
KW - Cardiac pacemaker
KW - Clinical practice guidelines
KW - Quality indicators
UR - http://www.scopus.com/inward/record.url?scp=85121278247&partnerID=8YFLogxK
U2 - 10.1093/europace/euab193
DO - 10.1093/europace/euab193
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34455442
AN - SCOPUS:85121278247
SN - 1099-5129
VL - 24
SP - 165
EP - 172
JO - Europace
JF - Europace
IS - 1
ER -